Endothelial dysfunction: cardiovascular risk factors, therapy, and outcome

Hadi A R Hadi, Cornelia S Carr, Jassim Al Suwaidi, Hadi A R Hadi, Cornelia S Carr, Jassim Al Suwaidi

Abstract

Endothelial dysfunction is a well established response to cardiovascular risk factors and precedes the development of atherosclerosis. Endothelial dysfunction is involved in lesion formation by the promotion of both the early and late mechanisms of atherosclerosis including up-regulation of adhesion molecules, increased chemokine secretion and leukocyte adherence, increased cell permeability, enhanced low-density lipoprotein oxidation, platelet activation, cytokine elaboration, and vascular smooth muscle cell proliferation and migration. Endothelial dysfunction is a term that covers diminished production/availability of nitric oxide and/or an imbalance in the relative contribution of endothelium-derived relaxing and contracting factors. Also, when cardiovascular risk factors are treated the endothelial dysfunction is reversed and it is an independent predictor of cardiac events. We review the literature concerning endothelial dysfunction in regard to its pathogenesis, treatment, and outcome.

Figures

Figure 1
Figure 1
The various factors that affect the endothelium and the consequences of endothelial dysfunction.

References

    1. Aanderud S, Krane H, Nordoy A. Influence of glucose, insulin and sera from diabetic patients on the prostacyclin synthesis in vitro in cultured human endothelial cells. Diabetologia. 1985;28:641–4.
    1. Aird WC. The role of the endothelium in severe sepsis and multiple organ dysfunction syndrome. Blood. 2003;101:3765–77.
    1. Al Suwaidi J, Hamasaki S, Higano ST, et al. Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction. Circulation. 2000;101:948–54.
    1. Al Suwaidi J, Higano ST, Holmes DR, et al. Obesity is an independent predictor of coronary endothelial dysfunction in patients with normal or mildly diseased coronary arteries. J Am Coll Cardiol. 2001;37:1523.
    1. Anderson TJ. Assessment and treatment of endothelial dysfunction in humans. J Am Coll Cardiol. 1999;34:631–8.
    1. Anderson TJ, Elstein E, Haber H, et al. Comparative study of ACE-inhibition, angiotensin II antagonism, and calcium channel blockade on flow-mediated vasodilation in patients with coronary disease (BANFF study) J Am Coll Cardiol. 2000;35:60–6.
    1. Anderson TJ, Gerhard MD, Meredith IT, et al. Systemic nature of endothelial dysfunction in atherosclerosis. Am J Cardiol. 1995;75:71B–74B.
    1. Anderson TJ, Uehata A, Gerhard MD, et al. Close relation of endothelial function in the human coronary and peripheral circulations. J Am Coll Cardiol. 1995;26:1235–41.
    1. Andrews NP, Prasad A, Quyyumi AA. N-acetylcysteine improves coronary and peripheral vascular function. J Am Coll Cardiol. 2001;37:117–23.
    1. Annuk M, Lind L, Linde T, et al. Impaired endothelium-dependent vasodilation in renal failure in humans. Nephrol Dial Transplant. 2001;16:302–6.
    1. Arbogast BW, Lee GM, Raymond TL. In vitro injury of porcine aortic endothelial cells by very-low-density lipoproteins from diabetic rat serum. Diabetes. 1982;31:593–9.
    1. Arcaro G, Cretti A, Balzano A, et al. Insulin causes endothelial dysfunction in humans: sites and mechanisms. Circulation. 2002;105:576–82.
    1. Avogaro A, Calo L, Piarulli F, et al. Effect of acute ketosis on the endothelial function of type 1 diabetic patients: the role of nitric oxide. Diabetes. 1999;48:391–7.
    1. Bakker SJ, Ijzerman RG, Teerlink T, et al. Cytosolic triglycerides and oxidative stress in central obesity: the missing link between excessive atherosclerosis, endothelial dysfunction and beta-cell failure? Atherosclerosis. 2000;148:17–21.
    1. Barnes PJ, Karin M. Nuclear factor-κ: a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med. 1997;336:1066–71.
    1. Bellamy MF, McDowell IFW, Ramsey MW, et al. Hyperhomocysteinemia after an oral methionine load acutely impairs endothelial function in healthy adults. Circulation. 1998;98:1848–52.
    1. Berger R, Stanek B, Hulsmann M, et al. Effects of endothelin A receptor A blockade on endothelial function in patients with chronic heart failure. Circulation. 2001;103:981–6.
    1. Bergholm R, Tiikkainen M, Vehkavaara S, et al. Lowering of LDL cholesterol rather than moderate weight loss improves endothelium-dependent vasodilatation in obese women with previous gestational diabetes. Diabetes Care. 2003;26:1667–72.
    1. Bijlstra PJ, Smits P, Lutterman JA, et al. Effect of long-term angiotensin-converting enzyme inhibition on endothelial function in patients with the insulin-resistance syndrome. J Cardiovasc Pharmacol. 1995;25:658–64.
    1. Blackwell KA, Sorenson JP, Richardson DM, et al. Mechanisms of aging-induced impairment of endothelium-dependent relaxations – role of tetrahydrobiopterin. Am J Physiol Heart Circ Physiol. 2004;287:H2448–53.
    1. Bloomgarden ZT. Endothelial dysfunction, neuropathy and the diabetic foot, diabetic mastopathy, and erectile dysfunction. Diabetes Care. 1998;21:183–9.
    1. Blum A, Simsolo C. The antiphospholipid syndrome and endothelial function. Isr Med Assoc J. 2004;6:556–8.
    1. Boers GH, Smals AG, Trijbels FJ, et al. Heterozygosity for homocystinuria in premature peripheral and cerebral occlusive arterial disease. N Engl J Med. 1985;313:709–15.
    1. Bogaty P, Hackett D, Davies G, et al. Vasoreactivity of the culprit lesion in unstable angina. Circulation. 1994;90:5–11.
    1. Boger RH, Bode-Boger SM, Szuba A, et al. Asymmetric dimethylarginine (ADMA): a novel risk factor for endothelial dysfunction: its role in hypercholesterolemia. Circulation. 1998;98:1842–7.
    1. Bonetti PO, Lerman LO, Lerman A. Endothelial dysfunction a marker of atherosclerotic risk. Arterioscler Thromb Vasc Biol. 2003;23:168.
    1. Bragulat E, de la Sierra A, Antonio MT, et al. Endothelial dysfunction in salt-sensitive essential hypertension. Hypertension. 2001;37:444–8.
    1. Brevetti G, Silvestro A, Di Giacomo S, et al. Endothelial dysfunction in peripheral arterial disease is related to increase in plasma markers of inflammation and severity of peripheral circulatory impairment but not to classic risk factors and atherosclerotic burden. Vasc Surg. 2003;38:374–9.
    1. Brevetti G, Silvestro A, Schiano V, et al. Endothelial dysfunction and cardiovascular risk prediction in peripheral arterial disease: additive value of flow-mediated dilation to ankle-brachial pressure index. Circulation. 2003;108:2093–8.
    1. Burke AP, Farb A, Malcolm GT, et al. Coronary risk factors and plaque morphology in men with coronary artery disease who died suddenly. N Engl J Med. 1997;336:1276–82.
    1. Bürrig KF. The endothelium of advanced arteriosclerotic plaques in humans. Arterioscler Thromb. 1991;11:1678–89.
    1. Caballero AE, Arora S, Saouaf R, et al. Microvascular and macrovascular reactivity is reduced in subjects at risk for type 2 diabetes. Diabetes. 1999;48:1856–62.
    1. Calles-Escandon J, Ballor D, Harvey-Berino J, et al. Amelioration of the inhibition of fibrinolysis in elderly, obese subjects by moderate energy intake restriction. Am J Clin Nutr. 1996;64:7–11.
    1. Calles-Escandon J, Cipolla M. Diabetes and endothelial dysfunction: a clinical perspective. Endocr Rev. 2001;22:36–52.
    1. Cardillo C, Campia U, Kilcoyne CM, et al. Improved endothelium-dependent vasodilation after blockade of endothelin receptors in patients with essential hypertension. Circulation. 2002;105:452–6.
    1. Casino PR, Kilcoyne CM, Cannon RO, et al. Impaired endothelium-dependent vascular relaxation in patients with hypercholesterolemia extends beyond the muscarinic receptor. Am J Cardiol. 1995;75:40–4.
    1. Casino PR, Kilcoyne CM, Quyyumi AA, et al. The role of nitric oxide in endothelium-dependent vasodilation of hypercholesterolemic patients. Circulation. 1993;88:2541–7.
    1. Celermajer DS, Adams MR, Clarkson P, et al. Passive smoking and impaired endothelium-dependent arterial dilatation in healthy young adults. N Engl J Med. 1996;334:150–4.
    1. Celermajer DS, Sorensen KE, Gooch VM, et al. Noninvasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet. 1992;340:1111–15.
    1. Cella G, Bellotto F, Tona F, et al. Plasma markers of endothelial dysfunction in pulmonary hypertension. Chest. 2001;120:1226–30.
    1. Chambers JC, Ueland PM, Obeid OA, et al. Improved vascular endothelial function after oral B vitamins: an effect mediated through reduced concentrations of free plasma homocysteine. Circulation. 2000;102:2479–83.
    1. Cheetham C, Collis J, O'Driscoll G, et al. Losartan, an angiotensin type 1 receptor antagonist, improves endothelial function in noninsulin-dependent diabetes. J Am Coll Cardiol. 2000;36:1461–6.
    1. Chen L, Chester M, Kaski JC. Clinical factors and angiographic features associated with premature coronary artery disease. Chest. 1995;108:364–9.
    1. Chou EJ, Keevil JG, Aeschlimann S, et al. Effect of ingestion of purple grape juice on endothelial function in patients with coronary heart disease. Am J Cardiol. 2001;88:553–5.
    1. Cipolla MJ. Elevated glucose potentiates contraction of isolated rat resistance arteries and augments protein kinase C-induced intracellular calcium release. Metabolism. 1999;48:1015–22.
    1. Clarke R, Daly L, Robinson K, et al. Hyperhomocysteinemia: an independent risk factor for vascular disease. N Engl J Med. 1991;324:1149–55.
    1. Clarke SC, Schofield PM, Grace AA, et al. Tamoxifen effects on endothelial function and cardiovascular risk factors in men with advanced atherosclerosis. Circulation. 2001;103:1497–502.
    1. Clarkson P, Celermajer DS, Donald AE, et al. Impaired vascular reactivity in insulin-dependent diabetes mellitus is related to disease duration and low density lipoprotein cholesterol levels. J Am Coll Cardiol. 1996;28:573–9.
    1. Cockcroft JR, Chowienczyk PJ, Benjamin N, et al. Preserved endothelium-dependent vasodilatation in patients with essential hypertension. N Engl J Med. 1994;330:1081–3.
    1. Cosentino F, Luscher TF. Endothelial dysfunction in diabetes mellitus. J Cardiovasc Pharmacol. 1998;32(Suppl 3):S54–61.
    1. Creager MA, Cooke JP, Mendelsohn MP, et al. Impaired vasodilation of forearm resistance vessels in hypercholesterolemic humans. J Clin Invest. 1990;86:228–34.
    1. Creager MA, Gallagher SI, Girerd XJ, et al. L-arginine improves endothelium-dependent vasodilation in hypercholesterolemic humans. J Clin Invest. 1992;90:1248–53.
    1. Cushman M, Lumaitre RN, Kuller LH, et al. Fibrinolytic activation markers predict myocardial infarction in the elderly. The cardiovascular health study. Arterioscler Thromb Vasc Biol. 1999;19:493–8.
    1. Dagenais GR, Yusuf S, Bourassa MG, et al. Effects of ramipril on coronary events in high-risk persons: results of the Heart Outcomes Prevention Evaluation Study. Circulation. 2001;104:522–6.
    1. Davies MJ, Woolf N, Rowles PM, et al. Morphology of the endothelium over atherosclerotic plaques in human coronary arteries. Br Heart J. 1988;60:459–64.
    1. Deanfield J, Donald A, Ferri C, et al. Endothelial function and dysfunction. Part I: methodological issues for assessment in the different vascular beds: a statement by the Working Group on Endothelin and Endothelial Factors of the European Society of Hypertension. J Hypertens. 2005;23:7–17.
    1. De Catarina R, Libby P, Peng HB, et al. Nitric oxide decreases cytokine-induced endothelial activation: nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. J Clin Invest. 1995;96:60–8.
    1. De Mattia G, Bravi MC, Laurenti O, et al. Reduction of oxidative stress by oral N-acetyl-L-cysteine treatment decreases plasma soluble vascular cell adhesion molecule-1 concentrations in non-obese, non-dyslipidaemic, normotensive, patients with non-insulin-dependent diabetes. Diabetologia. 1998;41:1392–6.
    1. DeSouza CA, Shapiro LF, Clevenger CM, et al. Regular aerobic exercise prevents and restores age-related declines in endothelium-dependent vasodilation in healthy men. Circulation. 2000;102:1351–7.
    1. Dimitrow PP. Coronary endothelial dysfunction in patients with hypertrophic cardiomyopathy. Chest. 2002;121:1374.
    1. Dosquet C, Wautier MP, Guillausseau PJ, et al. Monokines and endothelial cell proliferation in patients with diabetes mellitus. Diabetes Metab. 1994;20:37–42.
    1. Duffy SJ, Keaney JF, Jr, Holbrook M, et al. Short- and long-term black tea consumption reverses endothelial dysfunction in patients with coronary artery disease. Circulation. 2001;104:151–6.
    1. Dupuis J, Tardif JC, Cernacek P, et al. Cholesterol reduction rapidly improves endothelial function after acute coronary syndromes. The RECIFE (Reduction of Cholesterol in Ischemia and Function of the Endothelium) trial. Circulation. 1999;99:3227–33.
    1. Elhadd TA, Khan F, Kirk G, et al. Influence of puberty on endothelial dysfunction and oxidative stress in young patients with type 1 diabetes. Diabetes Care. 1998;21:1990–6.
    1. ENCORE I Study. Effect of nifedipine and cerivastatin on coronary endothelial function in patients with coronary artery disease: the ENCORE I Study (Evaluation of Nifedipine and Cerivastatin on Recovery of Coronary Endothelial Function) Circulation. 2003;107:422–8.
    1. Evans M, Anderson RA, Graham J, et al. Ciprofibrate therapy improves endothelial function and reduces postprandial lipemia and oxidative stress in type 2 diabetes mellitus. Circulation. 2000;101:1773–9.
    1. Farouque HM, Meredith IT. The assessment of endothelial function in humans. Coron Artery Dis. 2001;12:445–54.
    1. Fasching P, Veitl M, Rohac M, et al. Elevated concentrations of circulating adhesion molecules and their association with microvascular complications in insulin-dependent diabetes mellitus. J Clin Endocrinol Metab. 1996;81:4313–17.
    1. Ferri C, Bellini C, Desideri G, et al. Circulating endothelin-1 levels in obese patients with the metabolic syndrome. Exp Clin Endocrinol Diabetes. 1997;105(Suppl 2):38–40.
    1. Ferri C, Desideri G, Valenti M, et al. Early up regulation of endothelial adhesion molecules in obese hypertensive men. Hypertension. 1999;34:568–73.
    1. Fichtlscherer S, Rosenberger G, Walter DH, et al. Elevated C-reactive protein level and impaired endothelial vasoreactivity in patients with coronary artery disease. Circulation. 2000;102:1000–6.
    1. Fuentes F, Lopez-Miranda J, Sanchez E, et al. Mediterranean and low-fat diets improve endothelial function in hypercholesterolemic men. Ann Intern Med. 2001;134:1115–19.
    1. Gazis A, White DJ, Page SR, et al. Effect of oral vitamin E (α-tocopherol) supplementation on vascular endothelial function in type 2 diabetes mellitus. Diabet Med. 1999;16:304–11.
    1. Gilligan DM, Guetta V, Panza JA, et al. Selective loss of microvascular endothelial function in human hypercholesterolemia. Circulation. 1994;90:35–41.
    1. Gilligan DM, Quyyumi AA, Cannon RO., III Effects of physiologic levels of estrogen on coronary vasomotor function in postmenopausal women. Circulation. 1994;89:2545–51.
    1. Gokce N, Keaney JF, Jr, Hunter LM, et al. Risk stratification for postoperative cardiovascular events via noninvasive assessment of endothelial function: a prospective study. Circulation. 2002;105:1567–72.
    1. Gokce N, Keaney JF, Jr, Hunter LM, et al. Predictive value of noninvasively determined endothelial dysfunction for long-term cardiovascular events in patients with peripheral vascular disease. J Am Coll Cardiol. 2003;41:1769–75.
    1. Gokce N, Vits JA. Thrombosis and hemorrhage. In: Loscalzo J, Schafer AI, editors. Clinical manifestation of endothelial dysfunction. Philadelphia, PA: Lippincott Williams & Wilkins; 2002. pp. 685–706.
    1. Goodfellow J, Bellamy MF, Ramsey MW, et al. Dietary supplementation with marine omega-3 fatty acids improves systemic large artery endothelial function in subjects with hypercholesterolemia. J Am Coll Cardiol. 2000;35:265–70.
    1. Guthikonda S, Sinkey C, Barenz T, et al. Xanthine oxidase inhibition reverses endothelial dysfunction in heavy smokers. Circulation. 2003;107:416–21.
    1. Halcox JP, Schenke WH, Zalos G, et al. Prognostic value of coronary vascular endothelial dysfunction. Circulation. 2002;106:653–8.
    1. Hamasaki S, Al Suwaidi J, Higano ST, et al. Attenuated coronary flow reserve and vascular remodeling in patients with hypertension and left ventricular hyperatrophy. J Am Coll Cardiol. 2000;35:1654–60.
    1. Harker LA, Harlan JM, Ross R. Effect of sulfinpyrazone on homocysteine-induced endothelial injury and arteriosclerosis in baboons. Circ Res. 1983;53:731–9.
    1. Hattori Y, Kasai K, Nakamura T, et al. Effect of glucose and insulin on immunoreactive endothelin-1 release from cultured porcine aortic endothelial cells. Metabolism. 1991;40:165–9.
    1. Heitzer T, Schlinzig T, Krohn K, et al. Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease. Circulation. 2001;104:2673–8.
    1. Hernandez-Perera O, Perez-Sala D, Navarro-Antolin J, et al. Effects of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors, atorvastatin and simvastatin, on the expression of endothelin-1 and endothelial nitric oxide synthase in vascular endothelial cells. J Clin Invest. 1998;101:2711–19.
    1. Hornig B, Landmesser U, Kohler C, et al. Comparative effect of ACE inhibition and angiotensin II type 1 receptor antagonism on bioavailability of nitric oxide in patients with coronary artery disease: role of superoxide dismutase. Circulation. 2001;103:799–805.
    1. Hsueh WA, Anderson PW. Hypertension, the endothelial cell, and the vascular complications of diabetes mellitus [clinical conference] Hypertension. 1992;20:253–63.
    1. Hung J, Lam JYT, Lacoste L, et al. Cigarette smoking acutely increases platelet thrombus formation in patients with coronary artery disease taking aspirin. Circulation. 1995;92:2432–6.
    1. Husain S, Andrews NP, Mulcahy D, et al. Aspirin improves endothelial dysfunction in atherosclerosis. Circulation. 1998;97:716–20.
    1. Huszka M, Kaplar M, Rejto L, et al. The association of reduced endothelium derived relaxing factor-NO production with endothelial damage and increased in vivo platelet activation in patients with diabetes mellitus. Thromb Res. 1997;86:173–80.
    1. Huvers FC, De Leeuw PW, Houben AJ, et al. Endothelium-dependent vasodilatation, plasma markers of endothelial function, and adrenergic vasoconstrictor responses in type 1 diabetes under near-normoglycemic conditions. Diabetes. 1999;48:1300–7.
    1. Janka HU. Platelet and endothelial function tests during metformin treatment in diabetes mellitus. Horm Metab Res Suppl. 1985;15:120–2.
    1. Johnstone MT, Creager SJ, Scales KM, et al. Impaired endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus. Circulation. 1993;88:2510–16.
    1. Kaufmann PA, Gnecchi-Ruscone T, di Terlizzi M, et al. Coronary heart disease in smokers. Vitamin C restores coronary microcirculatory function. Circulation. 2000;102:1233–8.
    1. Kinlay S, Ganz P. Role of endothelial dysfunction in coronary artery disease and implications for therapy. Am J Cardiol. 1997;80:11-I–16-I.
    1. Koh MS, Majewski BB, Rhodes EL. Diabetic serum stimulates the proliferation of endothelial cells in culture. Diabetes Res. 1985;2:287–9.
    1. Kubes P, Suzuki M, Granger DN. Nitric oxide: an endogenous modulator of leukocyte adhesion. Proc Natl Acad Sci U S A. 1991;88:4651–5.
    1. Lefer AM, Campbell B, Shin Y-K, et al. Simvastatin preserves the ischemic-reperfused myocardium in normocholesterolemic rat hearts. Circulation. 1999;100:178–84.
    1. Lentz SR, Sobey CG, Piegors DJ, et al. Vascular dysfunction in monkeys with diet-induced hyperhomocyst(e)inemia. J Clin Invest. 1996;98:24–9.
    1. Lerman A, Burnett JC., Jr Intact and altered endothelium in regulation of vasomotion. Circulation. 1992;86(Suppl III):III-12–III-19.
    1. Libby P. Current concepts of the pathogenesis of the acute coronary syndromes. Circulation. 2001;104:365–72.
    1. Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation. 2002;105:1135–43.
    1. Lissin LW, Cooke JP. Phytoestrogens and cardiovascular health. J Am Coll Cardiol. 2000;35:1403–10.
    1. Lorenzi M, Montisano DF, Toledo S, et al. High glucose induces DNA damage in cultured human endothelial cells. J Clin Invest. 1986;77:322–5.
    1. Lum H, Roebuck KA. Oxidant stress and endothelial cell dysfunction. Am J Physiol Cell Physiol. 2001;280:C719–41.
    1. Makimattila S, Virkamaki A, Groop PH, et al. Chronic hyperglycemia impairs endothelial function and insulin sensitivity via different mechanisms in insulin-dependent diabetes mellitus. Circulation. 1996;94:1276–82.
    1. Malamitsi-Puchner A, Sarandakou A, Tziotis J, et al. Serum levels of basic fibroblast growth factor and vascular endothelial growth factor in children and adolescents with type 1 diabetes mellitus. Pediatr Res. 1998;44:873–5.
    1. Mancini GBJ, Henry GC, Macaya C, et al. Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease. The TREND (Trial on Reversing Endothelial Dysfunction) Study. Circulation. 1996;94:258–65.
    1. Masumoto A, Hirooka Y, Hironaga K, et al. Effect of pravastatin on endothelial function in patients with coronary artery disease (cholesterol-independent effect of pravastatin) Am J Cardiol. 2001;88:1291–4.
    1. Mather KJ, Verma S, Anderson T. Improved endothelial function with metformin in type 2 diabetes mellitus. J Am Coll Cardiol. 2001;38:2131–2.
    1. McFarlane R, McCredie RJ, Bonney MA, et al. Angiotensin converting enzyme inhibition and arterial endothelial function in adults with type 1 diabetes mellitus. Diabet Med. 1999;16:62–6.
    1. Minamino T, Miyauchi H, Yoshida T, et al. The role of vascular cell senescence in atherosclerosis: antisenescence as a novel therapeutic strategy for vascular aging. Curr Vasc Pharmacol. 2004;2:141–8.
    1. Miyazaki H, Matsuka H, Itabe H, et al. Hemodialysis impairs endothelial function via oxidative stress. Effects of vitamin E-coated dialyzer. Circulation. 2000;101:1002–6.
    1. Modena MG, Bonetti L, Coppi F, et al. Prognostic role of reversible endothelial dysfunction in hypertensive postmenopausal women. J Am Coll Cardiol. 2002;40:505–10.
    1. Mullen MJ, Clarkson R, Donald AE, et al. Effect of enalapril on endothelial function in young insulin-dependent diabetic patients: a randomized, double blind study. J Am Coll Cardiol. 1998;31:1330–5.
    1. Multiple Risk Factor Intervention Trial Group. Multiple Risk Factor Intervention Trial: risk factor changes and mortality results. JAMA. 1982;248:1465–77.
    1. Myrup B, Mathiesen ER, Ronn B, et al. Endothelial function and serum lipids in the course of developing microalbuminuria in insulin-dependent diabetes mellitus. Diabetes Res. 1994;26:33–9.
    1. Napoli C, de Nigris F, Palinski W. Multiple roles of reactive oxygen species in the arterial wall. J Cell Biochem. 2001;82:674–82.
    1. Neri S, Bruno CM, Leotta C, et al. Early endothelial alterations in non-insulin-dependent diabetes mellitus. Int J Clin Lab Res. 1998;28:100–3.
    1. Neunteufl T, Heher S, Katzenschlager R, et al. Late prognostic value of flow-mediated dilation in the brachial artery of patients with chest pain. Am J Cardiol. 2000;86:207–10.
    1. Njolstad I, Arnesen E, Lund-Larsen PG. Smoking, serum lipids, blood pressure, and sex differences in myocardial infarction: a 12-year follow-up of the Finnmark study. Circulation. 1996;93:450–6.
    1. Nolan D, Watts GF, Herrmann SE, et al. Endothelial function in HIV-infected patients receiving protease inhibitor therapy: does immune competence affect cardiovascular risk? QJM. 2003;96:825–32.
    1. Nordt TK, Klassen KJ, Schneider DJ, et al. Augmentation of synthesis of plasminogen activator inhibitor type-1 in arterial endothelial cells by glucose and its implications for local fibrinolysis. Arterioscler Thromb. 1993;13:1822–8.
    1. O'Driscoll G, Green D, Maiorana A, et al. Improvement in endothelial function by angiotensin-converting enzyme inhibition in non-insulin-dependent diabetes mellitus. J Am Coll Cardiol. 1999;33:1506–11.
    1. O'Driscoll G, Green D, Rankin J, et al. Improvement in endothelial function by angiotensin converting enzyme inhibition in insulin-dependent diabetes mellitus. J Clin Invest. 1997;100:678–84.
    1. O'Driscoll G, Green D, Taylor RR. Simvastatin, an HMG-coenzyme A reductase inhibitor, improves endothelial function within 1 month. Circulation. 1997;95:1126–31.
    1. Panza JA, Casino PR, Kilcoyne CM, et al. Role of endothelium-derived nitric oxide in the abnormal endothelium-dependent vascular relaxation of patients with essential hypertension. Circulation. 1993;87:1468–74.
    1. Panza JA, Casino PR, Kilcoyne CM, et al. Impaired endothelium-dependent vasodilation in patients with essential hypertension: evidence that the abnormality is not at the muscarinic receptor level. J Am Coll Cardiol. 1994;23:1610–16.
    1. Panza JA, Quyyumi AA, Callahan TS, et al. Effect of antihypertensive treatment on endothelium-dependent vascular relaxation in patients with essential hypertension. J Am Coll Cardiol. 1993;21:1145–51.
    1. Paolisso G, Giugliano D. Oxidative stress and insulin action: is there a relationship? Diabetologia. 1996;39:357–63.
    1. Peng HB, Libby P, Liao JK. Induction and stabilization of IκBα by nitric oxide mediates inhibition of NF-κB. J Biol Chem. 1995;270:14214–19.
    1. Perticone F, Ceravolo R, Pujia A, et al. Prognostic significance of endothelial dysfunction in hypertensive patients. Circulation. 2001;104:191–6.
    1. Pistrosch F, Passauer J, Fischer S, et al. In type 2 diabetes, rosiglitazone therapy for insulin resistance ameliorates endothelial dysfunction independent of glucose control. Diabetes Care. 2004;27:484–90.
    1. Prasad A, Tupas-Habib T, Schenke WH, et al. Acute and chronic angiotensin-1 receptor antagonism reverses endothelial dysfunction in atherosclerosis. Circulation. 2000;101:2349–54.
    1. Prasad A, Zhu J, Halcox JP, et al. Predisposition to atherosclerosis by infections. Role of endothelial dysfunction. Circulation. 2002;106:184–90.
    1. Quere I, Hillaire-Buys D, Brunschwig J, et al. Effects of homocysteine on acetylcholine- and adenosine-induced vasodilation of pancreatic vascular bed in rats. Br J Pharmacol. 1997;122:351–7.
    1. Quyyumi AA, Dakak N, Diodati JG, et al. Effect of L-arginine on human coronary endothelium-dependent and physiologic vasodilation. J Am Coll Cardiol. 1997;30:1220–7.
    1. Rask-Madsen N, Ihlemann T, Krarup E, et al. Insulin therapy improves insulin-stimulated endothelial function in patients with type 2 diabetes and ischemic heart disease. Diabetes. 2001;50:2611–18.
    1. Rector TS, Bank AJ, Mullen KA, et al. Randomized, double-blind, placebo-controlled study of supplemental oral L-arginine in patients with heart failure. Circulation. 1996;93:2135–41.
    1. Ruschitzka F, Shaw S, Gygi D, et al. Endothelial dysfunction in acute renal failure. J Am Soc Nephrol. 1999;10:953–62.
    1. Ryan M, McInerney D, Owens D, et al. Diabetes and the Mediterranean diet: a beneficial effect of oleic acid on insulin sensitivity, adipocyte glucose transport and endothelium-dependent vasoreactivity. QJM. 2000;93:85–91.
    1. Salvolini E, Rabini RA, Martarelli D, et al. A study on human umbilical cord endothelial cells: functional modifications induced by plasma from insulin-dependent diabetes mellitus patients. Metabolism. 1999;48:554–7.
    1. Sasaki S, Higashi Y, Nakagawa K, et al. A low-calorie diet improves endothelium-dependent vasodilation in obese patients with essential hypertension. Am J Hypertens. 2002;15:302–9.
    1. Schächinger V, Britten MB, Zeiher AM. Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease. Circulation. 2000;101:1899–906.
    1. Schindler TH, Horing B, Buser PT, et al. Prognostic value of abnormal vasoreactivity of epicardial coronary arteries to sympathetic stimulation in patients with normal coronary angiograms. Arterioscler Thromb Vasc Biol. 2003;23:495–501.
    1. Selhub J, Jacques PF, Bostom AG, et al. Association between plasma homocysteine concentrations and extracranial carotid-artery stenosis. N Engl J Med. 1995;332:286–91.
    1. Sesso HD, Gaziano JM, Buring JE, et al. Coffee and tea intake and the risk of myocardial infarction. Am J Epidemiol. 1999;149:162–7.
    1. Skrha J, Vackova I, Kvasnicka J, et al. Plasma-free N-terminal fibronectin 30-kDa domain as a marker of endothelial dysfunction in type 1 diabetes mellitus. Eur J Clin Invest. 1990;20:171–6.
    1. Skyrme-Jones RA, O'Brien RC, Berry KL, et al. Vitamin E supplementation improves endothelial function in type I diabetes mellitus: a randomized, placebo-controlled study. J Am Coll Cardiol. 2000;36:94–102.
    1. Skyrme-Jones RA, O'Brien RC, Luo M, et al. Endothelial vasodilator function is related to low-density lipoprotein particle size and lowdensity lipoprotein vitamin E content in type 1 diabetes. J Am Coll Cardiol. 2000;35:292–9.
    1. Sorensen KE, Celermajer DS, Georgakopoulos D, et al. Impairment of endothelium-dependent dilation is an early event in children with familial hypercholesterolemia and is related to the lipoprotein (a) level. J Clin Invest. 1994;93:50–5.
    1. Stampfer MJ, Malinow MR, Willett WC, et al. A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians. JAMA. 1992;268:877–81.
    1. Stein JH, Carlsson CM, Papcke-Benson K, et al. The effects of lipid-lowering and antioxidant vitamin therapies on flow-mediated vasodilation of the brachial artery in older adults with hypercholesterolemia. J Am Coll Cardiol. 2001;38:1806–13.
    1. Steinberg HO, Brechtel G, Johnson A, et al. Insulin-mediated skeletal muscle vasodilation is nitric oxide dependent. A novel action of insulin to increase nitric oxide release. J Clin Invest. 1994;94:1172–9.
    1. Steinberg HO, Chaker H, Leaming R, et al. Obesity/insulin resistance is associated with endothelial dysfunction: implications for the syndrome of insulin resistance. J Clin Invest. 1996;97:2601–10.
    1. Stuhlinger MC, Tsao PS, Her JH, et al. Homocysteine impairs the nitric oxide synthase pathway: role of asymmetric dimethylarginine. Circulation. 2001;104:2569–75.
    1. Tack CJ, Ong MK, Lutterman JA, et al. Insulin-induced vasodilatation and endothelial function in obesity/insulin resistance. Effects of troglitazone. Diabetologia. 1998;41:569–76.
    1. Taddei S, Mattei P, Virdis A, et al. Effect of potassium on vasodilation to acetylcholine in essential hypertension. Hypertension. 1994;23:485–90.
    1. Taddei S, Virdis A, Ghiadoni L, et al. Age-related reduction of NO availability and oxidative stress in humans. Hypertension. 2001;38:274–9.
    1. Taddei S, Virdis A, Mattei P, et al. Vasodilation to acetylcholine in primary and secondary forms of human hypertension. Hypertension. 1993;21(6 Pt 2):929–33.
    1. Taddei S, Virdis A, Mattei P, et al. Aging and endothelial function in normotensive subjects and patients with essential hypertension. Circulation. 1995;91:1981–7.
    1. Tao J, Jin YF, Yang Z, et al. Reduced arterial elasticity is associated with endothelial dysfunction in persons of advancing age: comparative study of noninvasive pulse wave analysis and laser Doppler blood flow measurement. Am J Hypertens. 2004;17:654–9.
    1. Teragawa H, Kato M, Kurokawa JK, et al. Endothelial dysfunction is an independent factor responsible for vasospastic angina. Clin Sci (Lond) 2001;101:707–13.
    1. Thogersen AM, Jansson J, Boman K, et al. High plasminogen activator inhibitor and tissue plasminogen activator level in plasma precede a first acute myocardial infarction in both men and women: evidence for the fibrinolytic system as an independent primary risk factor. Circulation. 1998;98:2241–7.
    1. Thompson LP, Pinkas G, Weiner CP. Chronic 17 beta-estradiol replacement increases nitric oxide-mediated vasodilation of guinea pig coronary microcirculation. Circulation. 2000;102:445–51.
    1. Thorne S, Mullen MJ, Clarkson P, et al. Early endothelial dysfunction in adults at risk from atherosclerosis: different responses to L-arginine. J Am Coll Cardiol. 1998;32:110–15.
    1. Ting HH, Timimi FK, Haley EA, et al. Vitamin C improves endothelium dependent vasodilation in forearm resistance vessels of humans with hypercholesterolemia. Circulation. 1997;95:2617–22.
    1. Vehkavaara S, Yki-Jarvinen H. 3.5 years of insulin therapy with insulin glargine improves in vivo endothelial function in type 2 diabetes. Arterioscler Thromb Vasc Biol. 2001;24:325–30.
    1. Venkov CD, Rankin AB, Vaughan DE. Identification of authentic estrogen receptor in cultured endothelial cells. A potential mechanism for steroid hormone regulation of endothelial function. Circulation. 1996;94:727–33.
    1. Verhaar MC, Stroes E, Rabelink TJ. Folates and cardiovascular disease. Arterioscler Thromb Vasc Biol. 2002;22:6–13.
    1. Verhaar MC, Wever RMF, Kastelein JJP, et al. Effects of oral folic acid supplementation on endothelial function in familial hypercholesterolemia: a randomized placebo-controlled trial. Circulation. 1999;100:335–8.
    1. Vita JA, Yeung AC, Winniford M, et al. Effect of cholesterol-lowering therapy on coronary endothelial vasomotor function in patients with coronary artery disease. Circulation. 2000;102:846–51.
    1. Wakatsuki A, Okatani Y, Ikenoue N, et al. Effect of medroxyprogesterone acetate on endothelium-dependent vasodilation in postmenopausal women receiving estrogen. Circulation. 2001;104:1773–8.
    1. Walker HA, Dean TS, Sanders TA, et al. The phytoestrogen genistein produces acute nitric oxide-dependent dilation of human forearm vasculature with similar potency to 17β-estradiol. Circulation. 2001;103:258–62.
    1. Wang BY, Ho HK, Lin PS, et al. Regression of atherosclerosis: role of nitric oxide and apoptosis. Circulation. 1999;99:1236–41.
    1. Wassmann S, Laufs U, Stamenkovic D, et al. Raloxifene improves endothelial dysfunction in hypertension by reduced oxidative stress and enhanced nitric oxide production. Circulation. 2002;105:2083–91.
    1. Watts GF, Playford DA. Dyslipoproteinaemia and hyperoxidative stress in the pathogenesis of endothelial dysfunction in non-insulin dependent diabetes mellitus: a hypothesis. Atherosclerosis. 1998;141:17–30.
    1. Webb CM, Ghatei MA, McNeill JG, et al. 17 beta-estradiol decreases endothelin-1 levels in the coronary circulation of postmenopausal women with coronary artery disease. Circulation. 2000;102:1617–22.
    1. Webb CM, McNeill JG, Hayward CS, et al. Effects of testosterone on coronary vasomotor regulation in men with coronary heart disease. Circulation. 1999;100:1690–6.
    1. Woo KS, Chook P, Lolin YI, et al. Hyperhomocyst(e)inemia is a risk factor for arterial endothelial dysfunction in humans. Circulation. 1997;96:2542–4.
    1. Xiang GD, He YS, Dai XJ, et al. Angiotensin-converting enzyme gene and the brachial artery endothelial dysfunction in type 2 diabetes without angiopathy. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2004;21:355–9.
    1. Yaqoob M, Patrick AW, McClelland P, et al. Relationship between markers of endothelial dysfunction, oxidant injury and tubular damage in patients with insulin-dependent diabetes mellitus. Clin Sci (Colch) 1993;85:557–62.
    1. Yataco AR, Corretti MC, Gardner AW, et al. Endothelial reactivity and cardiac risk factors in older patients with peripheral arterial disease. Am J Cardiol. 1999;83:754–8.
    1. Yavuz D, Deyneli O, Akpinar I, et al. Endothelial function, insulin sensitivity and inflammatory markers in hyperprolactinemic premenopausal women. Eur J Endocrinol. 2003;149:187–93.
    1. Yokoyama I, Momomura S-I, Ohtake T, et al. Improvement of impaired myocardial vasodilatation due to diffuse coronary atherosclerosis in hypercholesterolemics after lipid-lowering therapy. Circulation. 1999;100:117–22.
    1. Yoshida M, Imaizumi T, Ando S, et al. Impaired forearm vasodilatation by acetylcholine in patients with hypertension. Heart Vessels. 1991;6:218–23.
    1. Zhang F, Slungaard A, Vercellotti GM, et al. Superoxide-dependent cerebrovascular effects of homocysteine. Am J Physiol. 1998;274:R1704–11.
    1. Ziccardi P, Nappo F, Giugliano G, et al. Reduction of inflammatory cytokine concentrations and improvement of endothelial functions in obese women after weight loss over one year. Circulation. 2002;105:804–9.

Source: PubMed

Sponsorer och medarbetare

Medicinska tillstånd

Läkemedelsinterventioner

3
Prenumerera